Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes

Nanjing Medical University

Status: Completed

Conditions: Type2 Diabetes

Study type: Observational

Funder types: Other

Identifiers

NCT03519529

ENDO20180426-01

Details and patient eligibility

About

Sex hormone-binding globulin(SHBG) is a surrogate marker of insulin resistance. This study aims at the characteristic and clinical significance of SHBG and testosterone in patients with type 2 diabetes(T2D).

Full description

The investigators recorded clinical factors, biochemical criterion such as serum levels of glucose and lipids, HbA1c, SHBG, testosterone, insulin, EPO, C-peptide, glucagon, microalbuminuria, glycemic variation via CGM, carotid plaque, ECG and ultrasonic cardiogram in patients with T2D who visited in the Department of Endocrinology at the Nanjing First Hospital from January 2015 to Aprol 2018. The relationship between levels of SHBG, testosterone and glycemic variation/diabetic complications are analysed.

Enrollment: 250 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

● Patients with T2D and the diagnostic criteria of T2D is according to the World Health Organization in 1999.

Exclusion criteria

• Patients use systemic steroidal anti-inflammatory drugs.
• Patients with an acute infection.
• Patients with acute complication of diabetes.